A case of pulmonary thromboembolism in thalassemia intermedia: Are these patients at risk for thrombotic events?

Annali Italiani di Medicina Interna

Volumn 15, Issue 3, 2000, Pages 218-220

  Ciceri, L ^a   Amato, M ^a   Cappellini, M D ^a   Fiorelli, G ^a  

^a Padiglione Granelli   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ANTAGONIST; HEPARIN; VASODILATOR AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BETA THALASSEMIA; CASE REPORT; FEMALE; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; LUNG SCINTISCANNING; RISK FACTOR; THALASSEMIA; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION TESTS; CASE REPORT; COMPARATIVE STUDY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMAN; INJECTIONS, INTRAVENOUS; MIDDLE AGE; PULMONARY EMBOLISM; RISK FACTORS; THALASSEMIA; THROMBOPHILIA;

EID: 0033795985     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Thromboembolic complications in beta thalassemia major
2. Thromboembolic events in beta thalassemia major: An Italian multicenter study
3. Hypercoagulability in patients with thalassemia intermedia
4. A chronic hypercoagulable state and life long platelet activation in beta-thalassemia major
5. In vivo platelet activation in beta thalassemia major reflected by increased platelet-thromboxane urinary metabolites
6. Pulmonary thromboembolism in thalassemic patients
7. In vivo platelet activation correlates with red cells anionic phospholipid exposure in patients with beta thalassemia major
8. Phosphatidylserine in the outer leaflet of red blood cells from beta thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
9. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell and beta thalassemia
10. Procoagulant activity of erythrocytes in thalassemia intermedia